Effects of Peptide YY on the Hypothalamic-Pituitary-Gonadal Axis in Healthy Men.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 03 2020
Historique:
received: 08 07 2019
accepted: 02 10 2019
pubmed: 20 10 2019
medline: 11 11 2020
entrez: 20 10 2019
Statut: ppublish

Résumé

Central and peripheral administration of peptide YY (PYY) has potent anorectic effects, and PYY analogs are under development as antiobesity treatments. Recent animal data suggest PYY may also influence the reproductive axis; however the effects of PYY on the human reproductive system are unknown. To investigate the effects of PYY administration on the reproductive axis in healthy young men. Single-blind, randomized, placebo-controlled crossover study. Clinical Research Facility, Imperial College Healthcare NHS Trust. Eighteen healthy eugonadal men (mean age 24.1 ± 0.9 years, mean body mass index 22.2 ± 0.4 kg/m2). Eight-hour intravenous infusion of 0.4 pmol/kg/min PYY3-36 or rate-matched vehicle infusion. Number of luteinizing hormone (LH) pulses, LH, follicle stimulating hormone (FSH), and testosterone levels. The number of LH pulses (mean number of LH pulses/8 hours: PYY 4.4 ± 0.3 vs vehicle 4.4 ± 0.4, P > .99), LH area under the curve (AUC) (PYY 1503 ± 79 IU.min/L vs vehicle 1574 ± 86 IU.min/L, P = .36), FSH AUC (PYY 1158 ± 513 IU.min/L vs vehicle 1199 ± 476 IU.min/L, P = .49) and testosterone AUC (PYY 10 485 ± 684 IU.min/L vs vehicle 11 133 ± 803 IU.min/L, P = .24) were similar during PYY and vehicle infusions. Acute intravenous infusion of 0.4 pmol/kg/min PYY does not affect the reproductive axis in healthy men.

Identifiants

pubmed: 31628465
pii: 5599746
doi: 10.1210/clinem/dgz103
pmc: PMC7093052
pii:
doi:

Substances chimiques

Biomarkers 0
Peptide YY 106388-42-5
Testosterone 3XMK78S47O
Luteinizing Hormone 9002-67-9
Follicle Stimulating Hormone 9002-68-0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N020472/1
Pays : United Kingdom
Organisme : Department of Health
ID : CS-2018-18-ST2-002
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R000484/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T006242/1
Pays : United Kingdom
Organisme : Department of Health
ID : RP-2014-05-001
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M004171/1
Pays : United Kingdom

Informations de copyright

© Endocrine Society 2019.

Références

Endocrinology. 2005 Mar;146(3):1403-10
pubmed: 15564330
J Clin Endocrinol Metab. 2014 Nov;99(11):E2317-24
pubmed: 25144632
Brain Res. 2005 May 10;1043(1-2):139-44
pubmed: 15862527
Lancet. 2016 Aug 20;388(10046):776-86
pubmed: 27423262
Nature. 2002 Aug 8;418(6898):650-4
pubmed: 12167864
Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1162-71
pubmed: 16390861
Lancet Public Health. 2017 May;2(5):e214-e222
pubmed: 29253487
Science. 1980 Mar 21;207(4437):1371-3
pubmed: 6766566
Obes Rev. 2012 Jun;13(6):509-17
pubmed: 22212682
JAMA. 2014 Sep 3;312(9):934-42
pubmed: 25182102
BMC Public Health. 2009 Mar 25;9:88
pubmed: 19320986
Endocrinology. 2005 Dec;146(12):5120-7
pubmed: 16150917
J Clin Endocrinol Metab. 2014 Jun;99(6):E953-61
pubmed: 24517142
J Clin Endocrinol Metab. 2011 Sep;96(9):2643-51
pubmed: 21896895
Am J Physiol Endocrinol Metab. 2007 Nov;293(5):E1385-92
pubmed: 17785504
Annu Rev Physiol. 2016;78:277-99
pubmed: 26442437
Gastroenterology. 2005 Nov;129(5):1430-6
pubmed: 16285944
N Engl J Med. 2003 Sep 4;349(10):941-8
pubmed: 12954742

Auteurs

Chioma Izzi-Engbeaya (C)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Sophie Jones (S)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Yoshibye Crustna (Y)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Pratibha C Machenahalli (PC)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Deborah Papadopoulou (D)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Manish Modi (M)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Christos Panayi (C)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Jessica Starikova (J)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Pei Chia Eng (PC)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Maria Phylactou (M)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Edouard Mills (E)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Lisa Yang (L)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Risheka Ratnasabapathy (R)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Mark Sykes (M)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Isabella Plumptre (I)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Ben Coumbe (B)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Victoria Wing (V)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Ewa Pacuszka (E)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Paul Bech (P)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

James Minnion (J)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

George Tharakan (G)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Tricia Tan (T)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Johannes Veldhuis (J)

Department of Internal Medicine, Mayo Clinic, Minnesota.

Ali Abbara (A)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Alexander N Comninos (AN)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK.

Waljit S Dhillo (WS)

Section of Endocrinology and Investigative Medicine, Department of Medicine, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH